Drug Treatments for Leading Endocrine and Metabolic Diseases to Reach $96.4 billion by 2011

Drug Treatments for Leading Endocrine and Metabolic Diseases. This Market to Reach $96.4 billion by 2011, says new report available from ReportBuyer.com.
By: Report Buyer
 
May 23, 2007 - PRLog -- Report Buyer, the online destination for business intelligence for major industry sectors has now added a new market report titled ‘Drug Treatments for Leading Endocrine and Metabolic Diseases ’
http://www.reportbuyer.com/go/BCC00029

Findings in the 167 page report include
•   The global market for prescription endocrine and metabolic disease drugs was $66.2 billion in 2005 and $72.3 billion in 2006. At a compounded annual growth rate (CAGR) of 5.2%, the market will reach $96.4 billion by 2011.
•   Drugs for hypercholesterolemia dominated the highest share of the market, worth almost $37.1 billion in 2006, a 51.3% share. By 2011 its share will drop slightly to 47.2% ($45.5 billion of the total market), though it will remain the largest sector of the market
•   Obesity drugs and treatment have the highest growth potential throughout the forecast period. A relatively small market, its growth however is booming at a CAGR of 23.8%. By 2011 the sector will be worth more than $4.0 billion.

Summary of the report:
•   The major current and emerging markets for prescription drugs for endocrine and metabolic diseases, including hypertension, infertility, thyroid diseases, hypercholesterolemia, and obesity
•   Historical market data from 2004, 2005, and 2006, in addition to five-year market forecasts with compounded annual growth rates through 2011
•   Discusses applications as well as current and upcoming technology and trends
•   Provides detailed patent analysis and profiles of the major companies in the biotechnology and pharmaceutical industries that provide products for the diseases covered in this report.  

Content:
Introduction
Executive Summary
Overview
Endocrine Diseases - Applications And Products
Metabolic Diseases - Applications And Products
Company Profiles
List Of Figures
Drug Treatments for Leading Endocrine and Metabolic Diseases is available in PDF format from Report Buyer. For more information go to: www.reportbuyer.com/go/BCC00029
Report Buyer product ID: BCC00029

About Report Buyer.
Report Buyer is a UK-based independent online store supplying business information on major industry sectors. These include the Automotive Industry, Banking & Finance, Energy & Utilities, Food & Drink, Telecoms and Pharma & Healthcare. The website now carries over 24,000 business information products, including market reports, studies and books. Report Buyer is the intelligent way to buy market research making it an essential resource for executives and information buyers worldwide. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest.

Website: www.reportbuyer.com
End
Source:Report Buyer
Email:Contact Author
Posted By:***@reportbuyer.com Email Verified
Tags:Drug Treatments, Endocrine And Metabolic Diseases
Industry:Biotech, Health, Medical
Location:London City - London, Greater - England
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share